Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Vinpocetine inhibits oligodendroglial precursor cell differentiation.
Rituximab induces clonal expansion of IgG memory B-cells in patients with inflammatory central nervous system demyelination.
Santhera receives first product approval: Health Canada approves Catena® for treatment of Friedreich's ataxia
Brain gadolinium enhancement along the ventricular and leptomeningeal regions in patients with aquaporin-4 antibodies in cerebral spinal fluid.
Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.
Progress in multiple sclerosis research in the last year.
Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis.
Mapi Pharma granted United States patent covering glatiramer depot for multiple sclerosis
The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity.
A telerehabilitation program by virtual reality-video games improves balance and postural control in multiple sclerosis patients.
Lodonal/LDN
In vitro Biological Characterization of IFN-β-1a major Glycoforms.
A Study to Evaluate the Long-term Safety, Tolerability and Effect of Daily Oral Laquinimod 0.6 mg on Disease Course in Subjects With Relapsing Multiple Sclerosis
Microvesicles: novel biomarkers for neurological disorders.
Genmab collaborator GSK starts new ofatumumab Phase III study in rare skin disorder
Diagnosis of exclusion: a case report of probable glatiramer acetate-induced eosinophilic myocarditis.
Natalizumab in progressive MS: Results of an open-label, phase 2A, proof-of-concept trial.
Intense immunosuppression in chronic progressive multiple sclerosis: the Kaiser study.
Excess of melanocytic nevi in a patient treated with natalizumab for multiple sclerosis.
[Controlled research on multiple sclerosis treated with electroacupuncture and acupoint injection].
Dynamic walking features and improved walking performance in multiple sclerosis patients treated with fampridine (4-aminopyridine).
Fingolimod Therapy in Early Multiple Sclerosis: An Efficacy Analysis of the TRANSFORMS and FREEDOMS Studies by Time Since First Symptom.
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis.
Medicare Part D payments for neurologist-prescribed drugs.
Don't stress about it!: Is stress management a disease-modifying therapy for multiple sclerosis?

Pages